Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Verastem, Inc. (NASDAQ: VSTM).

Full DD Report for VSTM

You must become a subscriber to view this report.


Recent News from (NASDAQ: VSTM)

This Cancer Stock is up Over 3900%
HENDERSON, NV / ACCESSWIRE / September 7, 2018 / A fascinating biotech firm we discovered PPCB (Propanc Biopharma, Inc.) erupted for over 7000% in the last ten trading session going from a low of $0.0039 to a high of over $0.28, the stock is still holding a substantial gain of 3976% as we sp...
Source: ACCESSWIRE IA
Date: September, 07 2018 01:18
Verastem Oncology announces investigator sponsored study on duvelisib in combination with venetoclax
Verastem (NASDAQ: VSTM ), operating as Verastem Oncology announces dosing of the first patient in a multicenter Phase I/II clinical trial at the Dana-Farber/Harvard Cancer Center of duvelisib in combination with venetoclax in patients with relapsed or refractory chronic lymphocytic leukemi...
Source: SeekingAlpha
Date: September, 06 2018 09:00
Verastem Oncology Announces Investigator Sponsored Study on Duvelisib in Combination with Venetoclax
Phase I/II Trial to Investigate Combination Therapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma to take place at Dana-Farber Cancer Institute Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, a biopharmaceutical compan...
Source: Business Wire
Date: September, 06 2018 07:00
A Big-Picture Analysis Of Verastem Oncology
Editor's note: Seeking Alpha is proud to welcome LonoTrader as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » As Verastem On...
Source: SeekingAlpha
Date: September, 05 2018 16:36
Small Caps Are Rising, Biotechs Can't Be Far Behind
Market Pulse The S&P 500 has finally emerged from its 7-month consolidation as it weaves its way back to chalking all-time highs. While that is an event worth acknowledging, it may not be as breathless a milestone when one realizes that the small cap Russell 2000 index led the market and...
Source: SeekingAlpha
Date: September, 05 2018 13:31
Verastem Oncology Appoints Robert E. Gagnon as Chief Financial Officer
Verastem, Inc. (Nasdaq: VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced the appointment of Robert E. Gagnon, an experienced financial executive, as Chief Financial Of...
Source: Business Wire
Date: August, 29 2018 16:05
Verastem's Duvelisib And The Competition: A Comparison
When I first covered Verastem ( VSTM ) in March, the stock had not yet started its awesome rise. I also had two major doubts about the company - its cash position, and its competitive position vis-a-vis Imbruvica. So, while I held a small position, I was fairly cautious. My money having almo...
Source: SeekingAlpha
Date: August, 28 2018 13:18
Week 35 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 35: Market conditions have generated a strong increase in positive breakout momentum and a decline negative momentum this week. The positive momentum gauge has moved out of the red from 19 up to a value of 51 at the end of the week. The yellow positive...
Source: SeekingAlpha
Date: August, 27 2018 09:01
After Hours Gainers / Losers (08/21/2018)
Top Gainers: LZB +19.3% . KEYS   +12.2%.   PSTG   +8.8% .  WMLP +7.1% . TVIX   +3.2% . More news on: La-Z-Boy Incorporated, Keysight Technologies Inc., Pure Storage, Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: August, 21 2018 17:38
Verastem: An Undervalued Rare Oncology Gem With Big Upcoming Catalysts
Editor's note: Seeking Alpha is proud to welcome Juha Natunen as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » Editor's not...
Source: SeekingAlpha
Date: August, 14 2018 22:50

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-114.534.3554.57744.271,384,619
2018-12-104.354.45014.524.301,792,622
2018-12-074.644.514.68694.451,523,474
2018-12-064.754.604.804.461,623,998
2018-12-055.184.845.3954.832,537,448

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-11124,731481,98125.8788Cover
2018-12-10173,014479,98236.0459Short
2018-12-07166,771539,50830.9117Cover
2018-12-06230,981522,81444.1803Short
2018-12-04242,249491,36749.3010Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VSTM.


About Verastem, Inc. (NASDAQ: VSTM)

Logo for Verastem, Inc. (NASDAQ: VSTM)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: VSTM)

      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: May, 15 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 03 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 10 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: March, 13 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 13 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 14 2018
      Annual statement of changes in beneficial ownership of securities
      Filing Type: 5Filing Source: edgar
      Filing Date: February, 06 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: January, 26 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: January, 04 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: December, 21 2017

       

       


      Daily Technical Chart for (NASDAQ: VSTM)

      Daily Technical Chart for (NASDAQ: VSTM)


      Stay tuned for daily updates and more on (NASDAQ: VSTM)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: VSTM)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VSTM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VSTM and does not buy, sell, or trade any shares of VSTM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/